Arslan, G. Et Al. 2022. Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified by Lentiviral Transduction in C57BL/6 EAE Model. 5th International Molecular Immunology & Immunogenetics Congress , (İzmir, Turkey), 89-90.

Arslan, G., Karaçay, M., Çelik, E., Güvenç Bayram, G., Yumuşak, E., Dündar, F., ... Yöyen Ermiş, D.(2022). Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified by Lentiviral Transduction in C57BL/6 EAE Model . 5th International Molecular Immunology & Immunogenetics Congress (pp.89-90). İzmir, Turkey

Arslan, Gözde Et Al. "Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified by Lentiviral Transduction in C57BL/6 EAE Model," 5th International Molecular Immunology & Immunogenetics Congress, İzmir, Turkey, 2022

Arslan, Gözde Et Al. "Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified by Lentiviral Transduction in C57BL/6 EAE Model." 5th International Molecular Immunology & Immunogenetics Congress , İzmir, Turkey, pp.89-90, 2022

Arslan, G. Et Al. (2022) . "Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified by Lentiviral Transduction in C57BL/6 EAE Model." 5th International Molecular Immunology & Immunogenetics Congress , İzmir, Turkey, pp.89-90.

@conferencepaper{conferencepaper, author={Gözde Arslan Et Al. }, title={Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified by Lentiviral Transduction in C57BL/6 EAE Model}, congress name={5th International Molecular Immunology & Immunogenetics Congress}, city={İzmir}, country={Turkey}, year={2022}, pages={89-90} }